Zydus, Daewoong collaborate to co-develop, market Leuprolide Acetate
.webp)
Zydus Worldwide DMCC, a wholly-owned subsidiary of Zydus Lifesciences Ltd and Daewoong Pharmaceutical Co Ltd, has entered into a licensing agreement to co-develop and commercialise Leuprolide Acetate for Depot Suspension in six dosage strengths for the United States (US) market, the company in a regulatory filing with the BSE.
The terms of the agreement will result in Zydus assuming full responsibility for the clinical development and commercialisation in the US market.
The company said that Daewoong will leverage its proprietary technology to produce Leuprolide Acetate for Depot Suspension in its manufacturing facilities located in Osong, South Korea. The agreement between the two companies also includes a profit share on future sales, the company said in its filing.
Talking about the development, the Managing Director of Zydus Lifesciences Ltd, Sharvil Patel, said, "Enabling access to affordable generic versions for patients in the US has been our ongoing commitment. This is an important milestone and we are happy to work with Daewoong for a generic version of Lupron Depot, empowering patients with access to critical therapy. This is yet another step to strengthen the Zydus' complex injectable portfolio."
CEO of Daewoong Pharmaceutical said, "Given the complexity, complex generic drug products like Lupron Depot do not exist to date and we aim to be the first company to manufacture the generic version of this complex, long-acting injectable Lupron Depot product."
Other Latest News
.webp)
Maharashtra Cabinet-led by Chief Minister Eknath Shinde on Thursday passed a resolution urging the Centre to confer country's highest civilian award, Bharat Ratna to veteran industrialist Ratan Tata who passed away in Mumbai in recognition of his achievements.
Tributes were paid to Padma Vibhushan Ratan Tata in the state cabinet meeting held today.
.webp)
Karnataka BJP President B Y Vijayendra on Thursday predicted fast-paced political developments in the state in the next few days, including change of Chief Minister over the MUDA 'scam'.
"Lot of political developments are certainly taking place in the state. In the next few days the kind of fast paced political developments will take place, which both you (media) and the people of the state will see," he told reporters here.
.webp)
In the newly-elected 90-member Haryana Assembly, 96 per cent MLAs (86) are crorepatis, while 13 per cent (12) have criminal cases against them, according to an analysis by poll rights body ADR.
An analysis of the affidavits of all the 90 winning candidates by the Association for Democratic Reforms (ADR) and Haryana Election Watch show a slight rise in the number of crorepati MLAs, from 93 per cent in 2019 to 96 per cent this time.
.webp)
US Ambassador to India, Eric Garcetti, expressed condolences on veteran industrialist, Ratan Tata's demise on Thursday and said that India, and the world have "lost a giant with a giant heart."
The Tata Sons Chairman Emeritus, 86, breathed his last on Wednesday night at Breach Candy hospital in Mumbai.
.webp)
India's Adani Group plans to build 10 gigawatts of overseas hydroelectric projects over the next few years, four sources familiar with the plans told Reuters, helping the conglomerate reach its net zero carbon emissions goal by 2050.
Billionaire owner Gautam Adani, whose businesses span from rice to cement, announced in 2022 the group would invest $100 billion over the next decade to develop green energy capabilities including setting up the world's largest solar energy park in western India.
.webp)
.webp)
.webp)
.webp)
.webp)
